Bio Platforms

EXCLUSIVE ONLINE CONTENT

5/1/2019

Caris Life Sciences Acquires Pharmatech

Caris Life Sciences recently announced it has acquired Pharmatech, Inc., a pioneer of the original Just-In-Time research system with the largest research-ready oncology network.

4/23/2019

Autolus Therapeutics Receives FDA Orphan Drug Designation

Autolus Therapeutics plc recently announced the US FDA has granted orphan drug designation to autologous enriched T-cells genetically modified with a retroviral vector to express two chimeric antigen receptors targeting CD19 and CD22 (AUTO3) for the treatment of acute lymphoblastic leukemia (ALL).